Lung cancer to replace breast cancer as ‘future face’ of women’s cancer in the UK
BASINGSTOKE, UK, October 25, 2012, PRNewswire – In the lead-up to Lung Cancer Awareness Month this November, the ‘future face’ of women’s cancer is being revealed. While new data published last month by Cancer Research UK suggests the number of women dying from breast cancer in the UK is in decline – expected to drop almost 30 percent by 2030 – the number of women dying from lung cancer is on the increase.1
Liz Darlison, Macmillan Consultant Nurse Specialist, University Hospitals of Leicester, says, “While the statistics paint a frightening picture, there’s a great deal that can be done to help ensure women are diagnosed earlier, treated earlier and live longer. By raising awareness of the tell-tale signs – for example, a persistent cough that lasts longer than three weeks – there’s the potential to save thousands of lives every year.”
Lung cancer currently accounts for around one fifth (21 per cent) of all cancer deaths in women, and kills more women each year than breast cancer, uterine cancer or ovarian cancer.2 Each year, Lung Cancer Awareness Month provides a vital platform from which to raise awareness of the signs and symptoms of the disease, and the need to diagnose it early. Lung Cancer Awareness Month will launch on the 1st November 2012.
“Once considered a man’s disease, we need to get the message out that anyone can get lung cancer,” commented Paula Chadwick, Chief Executive at the Roy Castle Lung Cancer Foundation. “Although it remains a devastating disease for many, if caught early, it can be treated more effectively.”
The success of initiatives such as the pink campaigns for breast cancer, a disease for which deaths among women are expected to fall almost 30% over the next 20 years,1 highlights how ‘awareness months’ can really help to turn-the-tide. But even though lung cancer has overtaken breast cancer to become the most common cause of cancer death among women in the UK,2 it fails to get the attention it deserves:
- During Breast Cancer Awareness Month in 2011, over 2,000 articles were reported in the UK media – three times greater than the number published on lung cancer during its awareness month3
- In the last 12 months, breast cancer was discussed or commented on 180 times by Parliament, compared to just 59 times for lung cancer – three times more mentions4
For real life stories of people affected by lung cancer, please visit http://www.roycastle.org/get-involved/Share-Your-Story.
Notes to Editor
About Lung Cancer Awareness Month
Lung Cancer Awareness Month is a nationwide campaign run by The Roy Castle Lung Cancer Foundation (RCLCF) (www.roycastle.org) and Macmillan Cancer Support (www.macmillan.org.uk) to increase awareness of the early signs and symptoms of the disease. It is now in its eighth year and takes place throughout November. The initiative is also supported by many other charities and organisations, including Lilly Oncology, Cancer Research UK, British Lung Foundation, Society of Great Britain, Department of Health and NICE. November 1st marks the launch of Lung Cancer Awareness Month 2012.
About Lung Cancer
Lung cancer is the UK’s biggest cancer killer and the second most common cancer in the UK after breast cancer.7 Around 41,428 people were diagnosed with lung cancer in 2009 (113 people a day).7 Lung cancer currently accounts for 6% of all deaths and 22% of all deaths from cancer in the UK.7
About Lilly Oncology
For more than four decades, Lilly Oncology, a division of Eli Lilly and Company, has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. To learn more about Lilly Oncology UK, please visit www.lilly.co.uk.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organisations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.
- Cancer Mortality Projections For Selected Cancers. Cancer Research UK Report 2012. Available at http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/mortality-projections/projections-selected-cancers. Accessed October 2012
- Cancer mortality for common cancers: Top ten causes of cancer death in females. Cancer Research UK 2010. Available at
http://www.cancerresearchuk.org/cancer-info/cancerstats/mortality/cancerdeaths/#Top3. Accessed October 2012
- Source: Global Factiva Media Analysis – 1st September 2011 to 1st September 2012
- Source: www.parliament.uk
- Holmberg L, Sandin F, Bray F, Richards M, Spicer J, Lambe M, Kint A, Peake M, Strand, T-E, Linklater K, Robinson D & Møller H. National comparisons of lung cancer survival in England, Norway and Sweden 2001- 2004: differences occur early in follow-up. Thorax, 2010; 65:436-441.
- Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009; 101(Suppl. 2):S115–24.
- Cancer Stats – Lung Cancer. Cancer Research UK. Available at http://www.cancerresearchuk.org/cancer-info/cancerstats/types/lung. Accessed October 2012
Right click for ‘SAVE LINK AS’ or ‘SAVE TARGET AS’ options
Lung cancer in the UK
The Roy Castle Lung Cancer Foundation
Be Clear on Cancer